|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
48,660,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Nkarta is a biopharmaceutical company focused on the discovery, development and commercialization of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies to treat cancer. Co. has two product candidates, NKX101 and NKX019. Both product candidates were generated using Co.'s NK cell engineering platform. NKX101 is designed to improve the power of innate NK biology to detect and kill cancerous cells. NKX019 is based on the ability to treat a variety of B-cell malignancies by targeting the CD19 antigen that is found on these types of cancerous cells, where CD19-targeted engineered NK cells, T cells and monoclonal antibodies have demonstrated clinical activity.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
5,000,000 |
5,000,000 |
5,000,000 |
5,000,000 |
| Total Buy Value |
$50,000,000 |
$50,000,000 |
$50,000,000 |
$50,000,000 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
2 |
2 |
2 |
2 |
| Total Shares Sold |
12,510 |
37,385 |
42,746 |
138,518 |
| Total Sell Value |
$154,387 |
$371,794 |
$393,775 |
$1,753,059 |
| Total People Sold |
2 |
5 |
6 |
6 |
| Total Sell Transactions |
2 |
7 |
14 |
32 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mahmood Nadir |
See Remarks |
• – – |
2022-08-08 |
4 |
OE |
$3.89 |
$29,175 |
D/D |
7,500 |
53,588 |
|
- |
|
| Brandenberger Ralph |
Chief Technical Officer |
• – – |
2022-08-08 |
4 |
AS |
$15.51 |
$179,783 |
D/D |
(11,593) |
7,800 |
|
- |
|
| Brandenberger Ralph |
Chief Technical Officer |
• – – |
2022-08-08 |
4 |
OE |
$0.41 |
$30,199 |
D/D |
11,593 |
19,393 |
|
- |
|
| Mahmood Nadir |
See Remarks |
• – – |
2022-07-25 |
4 |
AS |
$13.40 |
$100,480 |
D/D |
(7,500) |
46,088 |
|
- |
|
| Mahmood Nadir |
See Remarks |
• – – |
2022-07-25 |
4 |
OE |
$3.89 |
$29,175 |
D/D |
7,500 |
53,588 |
|
- |
|
| Brandenberger Ralph |
Chief Technical Officer |
• – – |
2022-07-25 |
4 |
AS |
$13.41 |
$40,230 |
D/D |
(3,000) |
7,800 |
|
- |
|
| Brandenberger Ralph |
Chief Technical Officer |
• – – |
2022-07-25 |
4 |
OE |
$0.41 |
$1,230 |
D/D |
3,000 |
10,800 |
|
- |
|
| Hastings Paul J |
Chief Executive Officer |
• • – |
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
280,461 |
|
- |
|
| Mahmood Nadir |
See Remarks |
• – – |
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
46,088 |
|
- |
|
| Hager Alicia J. |
Chief Legal Officer |
• – – |
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
20,800 |
|
- |
|
| Trager James |
Chief Scientific Officer |
• – – |
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
62,172 |
|
- |
|
| Brandenberger Ralph |
Sr. VP, Technical Operations |
• – – |
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
7,800 |
|
- |
|
| Brandenberger Ralph |
Sr. VP, Technical Operations |
• – – |
2022-06-03 |
4 |
AS |
$15.00 |
$62,100 |
D/D |
(4,140) |
5,300 |
|
- |
|
| Brandenberger Ralph |
Sr. VP, Technical Operations |
• – – |
2022-06-03 |
4 |
OE |
$0.41 |
$15,278 |
D/D |
4,140 |
9,440 |
|
- |
|
| George Simeon |
Director |
– • – |
2022-04-28 |
4 |
B |
$15.00 |
$19,999,995 |
I/I |
1,333,333 |
666,666 |
2.1 |
- |
|
| Shah Rajeev M. |
Director |
– • • |
2022-04-26 |
4 |
B |
$15.00 |
$33,000,000 |
I/I |
2,200,000 |
7,805,129 |
2.25 |
- |
|
| Hager Alicia J. |
Chief Legal Officer |
• – – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
12,800 |
|
- |
|
| Mahmood Nadir |
See Remarks |
• – – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
40,088 |
|
- |
|
| Hastings Paul J |
Chief Executive Officer |
• • – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
41,900 |
260,961 |
|
- |
|
| Brandenberger Ralph |
Sr. VP, Technical Operations |
• – – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,300 |
5,300 |
|
- |
|
| Rajangam Kanya |
Chief Medical Officer |
• – – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
12,800 |
|
- |
|
| Trager James |
Chief Scientific Officer |
• – – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
57,172 |
|
- |
|
| Brandenberger Ralph |
Sr. VP, Technical Operations |
• – – |
2021-12-01 |
4 |
AS |
$15.64 |
$64,750 |
D/D |
(4,140) |
0 |
|
- |
|
| Brandenberger Ralph |
Sr. VP, Technical Operations |
• – – |
2021-12-01 |
4 |
OE |
$0.41 |
$15,278 |
D/D |
4,140 |
4,140 |
|
- |
|
| Hastings Paul J |
Chief Executive Officer |
• • – |
2021-09-29 |
4 |
AS |
$26.53 |
$231,051 |
D/D |
(8,500) |
219,061 |
|
- |
|
127 Records found
|
|
Page 3 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
